Breast cancer cells in bone metastasis regions reportedly expressed sclerostin, and treatment of breast cancer cells with anti-sclerostin antibodies inhibited the proliferation and migration of these cells in cultures [95]. The gene discussed is SOST; the disease is breast carcinoma.